Principal Scientist, Process Analytical Technology Industrialisation jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 2 months ago

Principal Scientist, Process Analytical Technology Industrialisation

AstraZeneca is a global biopharmaceutical company focused on delivering life-changing medicines. The Principal Scientist in Process Analytical Technology will drive the design, development, and validation of enhanced control strategies in commercial manufacturing settings, collaborating with cross-functional teams to implement innovative monitoring and control tools globally.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Play a crucial role in driving our strategy in the design, development, and validation of high-quality enhanced control strategies by applying your expert knowledge in the areas of PAT, Chemometrics, advanced process monitoring and control tools, quality systems and global regulations
Collaborate with cross-functional teams, contribute to regulatory documentation, and lead projects implementing innovative monitoring and control tools to our commercial manufacturing platforms globally, with a strong focus on continuous manufacturing
Drive standards and apply Lean in the validation and technical transfer of models and/ or PAT tools supporting product control strategies across Operations
Bring a future focussed, innovative mindset to deliver further digitally oriented approaches, data science, predictive modelling and simulation, and artificial intelligence

Qualification

Process Analytical TechnologyChemometricsAdvanced process controlQuality by DesignPharmaceutical process equipmentGMP complianceData integritySafetyHealth & EnvironmentScientific excellenceLeadership

Required

Master's degree
Minimum of 10 years industrial experience (Analytical Chemistry, Pharmaceutical Sciences, or Engineering)
Demonstrated delivery in PAT, advanced process control or model predictive control in late phase/ early commercial pharmaceutical manufacturing including technology transfer
Well versed in ICH guidelines (Q2, Q8, Q9, Q10, Q13 and Q14), Quality by Design principles, development and implementation of enhanced approaches for project/product specific control strategies
Experience in authoring relevant sections of NDA/MAA and defence, support of PPQ/CPV, and PAI
Expert knowledge of pharmaceutical process equipment/technology for continuous processes
Demonstrated experience of ensuring compliance with operational requirements (GMP, GAMP, Process Safety, Data integrity, Change Control)
An understanding of the principles and management of Safety, Health & Environment (SHE)

Preferred

PhD Degree
Experience of working with contract manufacturing organisations to deliver effective PAT solutions
Track record of scientific excellence and externally recognized expertise in PAT with a strong and sustained publication record in this area, for example publications, patents, conference presentations
Demonstrated leadership with direct or matrix management of highly skilled scientists
Experience in the deployment of PAT in manufacturing technologies for multiple formulation deliveries (e.g. oral, inhaled or injectables)
Knowledge of PAT application in development or manufacturing of combination products is highly desirable

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

H1B Sponsorship

AstraZeneca has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (2)
2020 (11)

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Executive Director and Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase